¿Qué sabemos sobre los efectos del COVID-19 en latinos con cáncer? Actualizaciones y recomendaciones. En este video de discusión, el Dr. Narjust Duma...
(SPANISH) ¿Cómo ha afectado el COVID-19 el diagnóstico de cáncer y qué puede hacer usted al respecto? Es hora de recordar la importancia de la...
From the Targeted Therapies Patient Forum 2019, Dr. Joshua Bauml and Dr. Joshua Sabari discuss RET, MET and BRAF, the initial treatment and acquired...
In this video series, presented in April of 2020, GRACE Faculty and Members of the Board of Directors have a candid discussion regarding cancer and...
In this video series, presented in April of 2020, GRACE Faculty and Members of the Board of Directors have a candid discussion regarding cancer and...
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
View the full ON-Demand Video now! This live, virtual, interactive patient education event included presentations and panel discussions covering...
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.
Hello OutThere! This is Janine, GRACE's Community Outreach Team member. I've been a part of the Grace community since 2009, just before my husband was...
Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum!
The full unedited versions of the 2023 Targeted Therapies in Lung Cancer Patient Forum presentations from the Mainstage and Second Stage, are now available OnDemand. These topics will be edited and offered as shorter videos in the coming weeks.
Apply Online Now for this paid opportunity to tell your story!
Apply Online Now for this paid opportunity to tell your story!
GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview
If you want to keep up on what content GRACE is producing, or if there is a specific program you are interested in seeing throughout the years, there are many ways to find that information. One of the best tools is the navigation drop-down under EDUCATE.
Just found this site and am looking for some information about lung IMA. I was diagnosed May, 2020 and had left lower lung lobectomy. The tumor was small relatively 1.7cm x 1.0 cm (it had doubled in size following an incidental CT for kidney stone in 2019). No lymphatic, vascular or pleural spread but there was STAS. ,It was a solitary tumor, not the pneumatic type. My thoracic surgeon is following with every 6 month scans. So my next scan coming up in June will be 24 months cancer free, hopefully.
I am inquiring on behalf of my sister-in-law who was diagnosed with stage three colon and rectal cancer in July 2020. She is 53 years old and a former smoker. She underwent chemotherapy for six months, followed by six weeks of radiation, and in April 2020 she had surgery to remove the tumor in her sigmoid. At that time, 17 od her lymph nodes were removed and all were clear, so she was restaged to stage two.
We had an overwhelming response to our call for clinical trial participants who would be interested in creating educational content for others by sharing their experiences!
In this continued time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients.
I'm writing here for my mom, who is 90 and unable to participate directly. While her lung cancer is in remission, she has CHF and had a PleurX catheter placed a little over two months ago for right-side pleural effusion. At first, it caused significant enough pain that we considered removing it and returning to regular thoracentesis procedures, but the pain largely subsided after about a week. The pain returned a bit under a week ago and has been quite bad. Her cardiologist's presumption is that it slipped one way or another and is now in a troublesome position.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock